RSS

Leo Pharma

Dermatology specialist, LEO Pharma, has announced that the European Commission (EC) has granted marketing authorisation for its new biologic, Kyntheum (brodalumab), for the treatment of moderate-to-severe plaque psoriasis in adults within the EU. more

News

Schreiner supplies Needle-Trap, which is applied to heparin syringes to protect from needlestick injuries. more